We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
-2.76%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$5.27B
AUM Growth
+$804M
(+18%)
Cap. Flow
+$1.19B
Cap. Flow
% of AUM
22.6%
Top 10 Holdings %
Top 10 Hldgs %
6.53%
Holding
2,150
New
668
Increased
458
Reduced
360
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$49.8M |
| 2 |
DoorDash
DASH
|
+$40.6M |
| 3 |
Eli Lilly
LLY
|
+$33.4M |
| 4 |
Capital One
COF
|
+$33.1M |
| 5 |
Emerson Electric
EMR
|
+$31.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$116M |
| 2 |
Broadcom
AVGO
|
+$111M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$32.8M |
| 4 |
Rivian
RIVN
|
+$27.2M |
| 5 |
Petrobras
PBR
|
+$25.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.13% |
| 2 | Financials | 14.83% |
| 3 | Industrials | 13.9% |
| 4 | Healthcare | 11.78% |
| 5 | Consumer Discretionary | 11.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Frontier Group Holdings
ULCC
$1.41B
| $59.6K | ﹤0.01% |
+16,885
| New | +$77.2K |
|
1477
Akebia Therapeutics
AKBA
$343M
| $59K | ﹤0.01% |
+42,434
| New | +$58.3K |
|
1478
Geron
GERN
$956M
| $53.4K | ﹤0.01% |
+35,863
| New | +$54.5K |
|
1479
Sabre
SABR
$704M
| $52.3K | ﹤0.01% |
+36,064
| New | +$48K |
|
1480
Taysha Gene Therapies
TSHA
$1.59B
| $51.3K | ﹤0.01% |
+11,486
| New | +$53.4K |
|
1481
Gevo
GEVO
$380M
| $51.3K | ﹤0.01% |
+18,777
| New | +$38.9K |
|
1482
Precigen
PGEN
$1.93B
| $48.7K | ﹤0.01% |
+12,582
| New | +$51.6K |
|
1483
Ironwood Pharmaceuticals
IRWD
$645M
| $47.3K | ﹤0.01% |
+13,470
| New | +$55.2K |
|
1484
Grab
GRAB
$13.6B
| $46.2K | ﹤0.01% |
+12,628
| New | +$53.6K |
|
1485
Clover Health Investments
CLOV
$2.25B
| $44.9K | ﹤0.01% |
+25,532
| New | +$55.4K |
|
1486
Digital Turbine
APPS
$1.04B
| $43.7K | ﹤0.01% |
+15,175
| New | +$65.2K |
|
|
RC
1487
Ready Capital
RC
$265M
| $43.4K | ﹤0.01% |
26,759
-856,555
| -97% | -$1.64M |
|
1488
Clean Energy Fuels
CLNE
$432M
| $43K | ﹤0.01% |
+17,338
| New | +$40.4K |
|
1489
Community Health Systems
CYH
$383M
| $39.6K | ﹤0.01% |
+13,483
| New | +$43.7K |
|
|
EU
1490
enCore Energy
EU
$233M
| $39.3K | ﹤0.01% |
21,855
-144,784
| -87% | -$370K |
|
1491
Maravai LifeSciences
MRVI
$985M
| $37.1K | ﹤0.01% |
+13,113
| New | +$44.5K |
|
1492
iHeartMedia
IHRT
$546M
| $35.6K | ﹤0.01% |
+12,187
| New | +$40.3K |
|
1493
Cerus
CERS
$613M
| $34.8K | ﹤0.01% |
+19,145
| New | +$41.7K |
|
1494
Ribbon Communications
RBBN
$359M
| $26.2K | ﹤0.01% |
+12,356
| New | +$29.6K |
|
1495
Getty Images
GETY
$176M
| $22.9K | ﹤0.01% |
28,853
+551
| +2% | +$555 |
|
|
SVC
1496
Service Properties Trust
SVC
$1.08B
| $16K | ﹤0.01% |
+2,361
| New | +$24.6K |
|
1497
American Airlines Group
AAL
$9.9B
| – | – |
-638,404
| Closed | -$9.79M |
|
1498
Applied Optoelectronics
AAOI
$7.85B
| – | – |
-55,271
| Closed | -$1.93M |
|
|
AAT
1499
American Assets Trust
AAT
$1.49B
| – | – |
-87,474
| Closed | -$1.66M |
|
1500
Ameris Bancorp
ABCB
$5.77B
| – | – |
-39,928
| Closed | -$2.97M |
|
Similar funds
HSA
O
LIM
LFG
JIM
CTC
NL
BPWM
Y-Intercept (HK)'s Q1 2026 Portfolio in Review
As of Q1 2026, Y-Intercept (HK) held 2,150 positions worth $5.27B, up 18% from $4.47B the previous quarter. Its ten largest holdings account for 6.5% of the portfolio.
Y-Intercept (HK) deployed $1.19B of net new capital in Q1 2026, opening 668 new positions and adding to 458 existing holdings. Its largest new stake was Micron Technology: 127,057 shares worth $42.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Charles Schwab, an estimated $32.8M trimmed.
- Y-Intercept (HK)'s largest Q1 2026 buy was Micron Technology: 127,057 shares worth $42.9M.
- Y-Intercept (HK) added most to Boston Scientific in Q1 2026, an estimated $31M increase.
- Y-Intercept (HK)'s biggest Q1 2026 reduction was Charles Schwab, cutting an estimated $32.8M.
- Y-Intercept (HK) fully exited NVIDIA in Q1 2026, selling an estimated $116M.
- Y-Intercept (HK)'s ten largest holdings make up 6.5% of its $5.27B portfolio in Q1 2026.
- Y-Intercept (HK) opened 668 new positions and closed 654 in Q1 2026.
- Y-Intercept (HK)'s portfolio value rose 18% quarter-over-quarter to $5.27B.
Based on Y-Intercept (HK)'s 13F filing for Q1 2026, filed 27 Apr 2026.